A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis

Coronary Artery Disease

Volumn 8, Issue 5, 1997, Pages 293-298

  Kornowski, Ran ^a   Hong, Mun K ^a   Tio, Fermin O ^b   Choi, Suk K ^c   Bramwell, Orville ^a   Leon, Martin B ^a,d  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c Inje University   (South Korea)

^d Washington Cardiology Center   (United States)

Author keywords

Heparin; Local delivery; Restenosis; Stents; Urokinase

Indexed keywords

FIBRINOGEN; HEPARIN; UROKINASE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; STENT; SWINE;

EID: 0030745845     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199705000-00006     Document Type: Article

References (40)

1. Ellis SG, Savage M, Fischman D, Baim DS, Leon M, Goldberg S, et al.: Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992, 86:1836-1844.
2. Foley JB, Penn IM, Brown RIG, Murray-Parsons N, White J, Galligar L, et al.: Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center. Am Heart J 1993, 125:686-694.
3. Kastrati A, Schomig A, Dietz R, Neumann FJ, Richardt S: Time course of restenosis during the first year after emergency coronary stenting. Circulation 1993, 87:1498-1505.
4. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T: Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol 1995, 76:117-120.
5. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Wong SC, et al.: Endovascular stents reduce restenosis by eliminating geometric arterial remodeling: a serial intravascular ultrasound study [abstract]. J Am Colt Cardiol 1995, 25:36A.
6. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. for the Stent Restenosis Study Investigators: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994, 331:496-501.
7. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G. et al. for the BENESTENT Study Group: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994, 331:489-495.
8. Schatz RA, Palmaz JC, Tio F, Garcia F, Garcia O, Reuter SR: Balloon-expandable intracoronary stents in the adult dog. Circulation 1987, 76:450-457.
9. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes D: Restenosis after balloon angioplasty. A practical proliferative model in the porcine coronary arteries. Circulation 1990, 82:2190-2200.
10. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al.: Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
11. 1 Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg KA, King SB III: Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis, J Am Coll Cardiol 1992, 20:467-474.
12. Dussaillant GR, Mintz GS, Pichard A, Kent KM, Satler LF, Popma JJ, et al.: Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995, 26:720-724.
13. Gordon PC, Gibson M, Cohen DJ, Carroza JP, Kuntz RE, Baim DS: Mechanisms of restenosis and redilation within coronary stents - quantitative angiographic assessment. J Am Coll Cardiol 1993, 21:1166-1174.
14. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW: Platelet-derived growth factor promote smooth muscle cell migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992, 89:507-511.
15. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132.
16. Fager G: Thrombin and proliferation of smooth muscle cells. Circ Res 1995, 77:645-650.
17. Clowes AW, Karnovsky MJ: Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977, 265:625-626.
18. Guyton JRR, Rosenberg RD, Clowes AW, Karnovsky MJ: Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 1980, 46:625-634.
19. Edelman ER, Adams DH, Karnovsky MJ: Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 1990, 87:3773-3777.
20. Kanamasa K, Ishida N, Kato H, Sakamoto S, Nakabayashi T, Otani N, et al.: Low dose tPA infusion for 7 days prevents intimal hyperplasia following balloon angioplasty in atherosclerotic rabbits [abstract]. Circulation 1993, 88 (suppl 1):1656
21. Camenzind E, Kint PP, Di Mario C, Ligthart J, Van der Giessen W, Boersma E, et al.: Intracoronary heparin delivery in humans. Acute feasibility and long-term results. Circulation 1995, 92:2463-2472.
22. Mitchel JF, Fram DB, Palme DF, Foster R, Hirst JA, Aznn MA, et al.: Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation 1995, 91:785-793.
23. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al.: Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
24. Nugent MA, Karnovsky MJ, Edelman ER: Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res 1993, 73:1051-1060.
25. Faxon DP, Spiro TE, Minor S, Cote G, Douglas J, Gottlieb R, et al. and the ERA Investigators: Low molecular weight heparin in prevention of restenosis after angioplasty. Circulation 1994, 90:908-914.
26. Brack MJ, Ray S, Chauhan A, Fox J, Hubner PJB, Schofield P, et al.: The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial. J Am Coll Cardiol 1995, 26:947-954.
27. Mintz GS, Popma JJ, Richard AD, Kent KM, Satler LF, Wong CS, et al.: Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 1996, 94:35-43.
28. Hong MK, Wong SC, Farb A, Mehlman MD, Virmani R, Barry JJ, et al.: Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery. Cathet Cardiovasc Diagn 1995, 34:263-270.
29. Edelman ER, Karnovsky MJ: Contrasting effect of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 1994, 89:770-776.
30. Rogers C, Karnovsky MJ, Edelman ER: Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 1993, 88:1215-1121
31. Hirsh J, Fuster V: Guide to anticoagulant therapy part 1. Heparin. Circulation 1994, 89:1449-1468.
32. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon J: The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost 1995, 74:552-559.
33. Willerson JT, Yao SK, McNatt J, Benedict C, Anderson H, Golino P, et al.: Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Nad Acad Sci USA 1991, 88:10624-10629.
34. Hajjar KA, Hamel NM: Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J Biol Chem 1990, 265:2908-2916.
35. Schafer BM, Maier K, Eichkhoff U, Todd RF, Kramer MD: Plasminogen activation in healing human wounds. Am J Pathol 1994, 144:1269-1280.
36. Morishita H, Hattori R, Aoyama T, Kawai C, Yui Y: The intracoronary administration of urokinase following direct PTCA for acute myocardial infarction reduces early restenosis. Am Heart J 1992, 123:1153-1156.
37. Mehan VK, Meier B, Urban P: Influence on early outcome and restenosis of urokinase before elective coronary angioplasty. Am J Cardiol 1993, 72:106-108
38. Van der Gissen WJ, Violaris AG, van Beusekom HMM, Di Mario C, van Meegen JR, Serruys PW, et al.: Acute local delivery of drugs with incremental molecular size in normal coronary arteries of pigs [abstract]. Eur Heart J 1994, 15:559.
39. 3 catheter [abstract]. J Am Coll Cardiol 1994, 23:186A.
40. Lincoff M, Topol EJ, Ellis SG: Local drug delivery for the prevention of restenosis. Circulation 1994. 90:2070-2084.